277 related articles for article (PubMed ID: 28963941)
21. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
[TBL] [Abstract][Full Text] [Related]
22. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
[TBL] [Abstract][Full Text] [Related]
23. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
[TBL] [Abstract][Full Text] [Related]
25. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Lyu Z; Ji X; Chen G; An B
Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
[TBL] [Abstract][Full Text] [Related]
26. Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
Hu JJ; Wang H; Pan CW; Lin MX
Microb Pathog; 2018 Jun; 119():86-92. PubMed ID: 29604422
[TBL] [Abstract][Full Text] [Related]
27. Magnesium isoglycyrrhizinate attenuates D-galactosamine/lipopolysaccharides induced acute liver injury of rat via regulation of the p38-MAPK and NF-κB signaling pathways.
Wang W; Li X; Xu J
Immunopharmacol Immunotoxicol; 2018 Jun; 40(3):262-267. PubMed ID: 29486613
[TBL] [Abstract][Full Text] [Related]
28. Prostacyclin mimetics afford protection against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Misawa H; Ohashi W; Tomita K; Hattori K; Shimada Y; Hattori Y
Toxicol Appl Pharmacol; 2017 Nov; 334():55-65. PubMed ID: 28887131
[TBL] [Abstract][Full Text] [Related]
29. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
[TBL] [Abstract][Full Text] [Related]
30. Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells.
Yang S; Kuang G; Zhang L; Wu S; Zhao Z; Wang B; Yin X; Gong X; Wan J
Front Immunol; 2020; 11():285. PubMed ID: 32158448
[TBL] [Abstract][Full Text] [Related]
31. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy.
Lv H; Fan X; Wang L; Feng H; Ci X
Int J Biol Macromol; 2018 Nov; 119():240-248. PubMed ID: 30031824
[TBL] [Abstract][Full Text] [Related]
32. β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways.
Cho HI; Hong JM; Choi JW; Choi HS; Hwan Kwak J; Lee DU; Kook Lee S; Lee SM
Eur J Pharmacol; 2015 Oct; 764():613-621. PubMed ID: 26254779
[TBL] [Abstract][Full Text] [Related]
33. Effects of globin digest and its active ingredient Trp-Thr-Gln-Arg on galactosamine/lipopolysaccharide-induced liver injury in ICR mice.
Sasakawa Y; Kominami A; Yamamoto K; Nakaoka F; Nakamura M; Nakao M; Abe M; Fukuhama C; Kagawa K
Life Sci; 2012 Jan; 90(5-6):190-9. PubMed ID: 22154906
[TBL] [Abstract][Full Text] [Related]
34. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
[TBL] [Abstract][Full Text] [Related]
35. Quercetin protects mouse liver against CCl₄-induced inflammation by the TLR2/4 and MAPK/NF-κB pathway.
Ma JQ; Li Z; Xie WR; Liu CM; Liu SS
Int Immunopharmacol; 2015 Sep; 28(1):531-9. PubMed ID: 26218279
[TBL] [Abstract][Full Text] [Related]
36. Triptolide attenuate the oxidative stress induced by LPS/D-GalN in mice.
Lu Y; Bao X; Sun T; Xu J; Zheng W; Shen P
J Cell Biochem; 2012 Mar; 113(3):1022-33. PubMed ID: 22065336
[TBL] [Abstract][Full Text] [Related]
37. Diallyl sulfide protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice.
Li M; Wang S; Li X; Jiang L; Wang X; Kou R; Wang Q; Xu L; Zhao N; Xie K
Food Chem Toxicol; 2018 Oct; 120():500-509. PubMed ID: 30075314
[TBL] [Abstract][Full Text] [Related]
38. Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation.
Li X; Gou C; Yang H; Qiu J; Gu T; Wen T
Scand J Gastroenterol; 2014 Aug; 49(8):993-1000. PubMed ID: 24797709
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of UII/UTR system relieves acute inflammation of liver through preventing activation of NF-κB pathway in ALF mice.
Liang DY; Liu LM; Ye CG; Zhao L; Yu FP; Gao DY; Wang YY; Yang ZW; Wang YY
PLoS One; 2014; 8(6):e64895. PubMed ID: 23755157
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
